Albon label

Albon

Albon Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

WARNING: Not for human use.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

INDICATIONS AND USAGE: Albon is indicated for the treatment of respiratory, genitourinary tract, enteric, and soft tissue infections in dogs and cats:

 
tonsillitis
 
pharyngitis
 
bronchitis
 
pneumonia
 
cystitis
 
nephritis
 
metritis
 
pyometra
 
pustular dermatitis
 
anal gland infections
 
abscesses
 
wound infections
 
bacterial enteritis
 
canine salmonellosis
 
bacterial enteritis associated with coccidiosis in dogs

when caused by streptococci, staphylococci, escherichia, salmonella, klebsiella, proteus or shigella organisms sensitive to sulfadimethoxine.

Limitations: Sulfadimethoxine is not effective in viral or rickettsial infections, and as with any antibacterial agent, occasional failures in therapy may occur due to resistant microorganisms. The usual precautions in sulfonamide therapy should be observed.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

DESCRIPTION: Albon is a low-dosage, rapidly absorbed, long-acting sulfonamide, effective for the treatment of a wide range of bacterial infections commonly encountered in dogs and cats.

Sulfadimethoxine is a white, almost tasteless and odorless compound. Chemically, it is N1-(2,6-dimethoxy-4-pyrimidinyl) sulfanilamide. The structural formula is:

Chemical Structure
Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Albon Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Albon Manufacturers

  • Zoetis Inc.
    Albon | Zoetis Inc.
    No Recall

    Albon | Zoetis Inc.

    Albon | Zoetis Inc.

    Initial Dose: 25 mg/lb (55 mg/kg) of animal body weight.

    Subsequent Daily Doses: 12.5 mg/lb (27.5 mg/kg) of animal body weight.

    Dogs and cats should receive 1 teaspoonful of Albon Oral Suspension 5% per 10 lb of body weight (25 mg/lb or 55 mg/kg) as an initial dose, followed by 1/2 teaspoonful per 10 lb of body weight (12.5 mg/lb or 27.5 mg/kg) every 24 hours thereafter. Representative weights and doses are indicated in the following table:

    Animal Weight Initial Dose
    25 mg/lb
    (55 mg/kg) Subsequent Daily Doses
    12.5 mg/lb
    (27.5 mg/kg) 5 lb (2.2 kg) 1/2 tsp (2 1/2 mL) 1/4 tsp (1 1/4 mL) 10 lb (4.5 kg) 1 tsp (5 mL) 1/2 tsp (2 1/2 mL) 20 lb (9.1 kg) 2 tsp (10 mL) 1 tsp (5 mL) 40 lb (18.2 kg) 4 tsp (20 mL) 2 tsp (10 mL) 80 lb (36.4 kg) 8 tsp (40 mL) 4 tsp (20 mL)

    Treatment may be initiated with Albon Injection 40% to obtain effective blood levels almost immediately or to facilitate treatment of the fractious animal.

    Length of treatment depends on the clinical response. In most cases treatment for 3–5 days is adequate. Treatment should be continued until the animal is asymptomatic for 48 hours.

  • Pfizer Animal Health
    Albon | Pfizer Animal Health
    No Recall

    Albon | Pfizer Animal Health

    Albon | Pfizer Animal Health

    Initial Dose: 25 mg/lb (55 mg/kg) of animal body weight.

    Subsequent Daily Doses: 12.5 mg/lb (27.5 mg/kg) of animal body weight.

    Dogs and cats should receive 1 teaspoonful of Albon Oral Suspension 5% per 10 lb of body weight (25 mg/lb or 55 mg/kg) as an initial dose, followed by 1/2 teaspoonful per 10 lb of body weight (12.5 mg/lb or 27.5 mg/kg) every 24 hours thereafter. Representative weights and doses are indicated in the following table:

    Animal Weight Initial Dose
    25 mg/lb
    (55 mg/kg) Subsequent Daily Doses
    12.5 mg/lb
    (27.5 mg/kg) 5 lb (2.2 kg) 1/2 tsp (2 1/2 mL) 1/4 tsp (1 1/4 mL) 10 lb (4.5 kg) 1 tsp (5 mL) 1/2 tsp (2 1/2 mL) 20 lb (9.1 kg) 2 tsp (10 mL) 1 tsp (5 mL) 40 lb (18.2 kg) 4 tsp (20 mL) 2 tsp (10 mL) 80 lb (36.4 kg) 8 tsp (40 mL) 4 tsp (20 mL)

    Treatment may be initiated with Albon Injection 40% to obtain effective blood levels almost immediately or to facilitate treatment of the fractious animal.

    Length of treatment depends on the clinical response. In most cases treatment for 3–5 days is adequate. Treatment should be continued until the animal is asymptomatic for 48 hours.

  • Pfizer Animal Health
    Albon | Pfizer Animal Health
    No Recall

    Albon | Pfizer Animal Health

    Albon | Pfizer Animal Health

    Initial Dose: 25 mg/lb (55 mg/kg) of animal body weight.

    Subsequent Daily Doses: 12.5 mg/lb (27.5 mg/kg) of animal body weight.

    For ease of administration in animals of varying weights, 3 tablet sizes are provided. The following table indicates how dosage may be adjusted depending on tablet size and body weight. Subsequent doses should be given at 24-hour intervals.

    Tablet Size Approximate Animal Weight Initial Dose
    25 mg/lb
    (55 mg/kg) Subsequent Daily Doses
    12.5 mg/lb
    (27.5 mg/kg) 125 mg 5 lb (2.2 kg) 1 tablet 1/2 tablet 250 mg 10 lb (4.5 kg) 1 tablet 1/2 tablet 500 mg 20 lb (9.1 kg) 1 tablet 1/2 tablet

    Treatment may be initiated with Albon Injection 40% to obtain effective blood levels almost immediately or to facilitate treatment of the fractious animal.

    Length of treatment depends on the clinical response. In most cases treatment for 3–5 days is adequate. Treatment should be continued until the animal is asymptomatic for 48 hours.

  • Zoetis Inc.
    Albon | Zoetis Inc.
    No Recall

    Albon | Zoetis Inc.

    Albon | Zoetis Inc.

    DOSAGE AND ADMINISTRATION:

    Initial Dose: 25 mg/lb (55 mg/kg) of animal body weight.

    Subsequent Daily Doses: 12.5 mg/lb (27.5 mg/kg) of animal body weight.

    For ease of administration in animals of varying weights, 3 tablet sizes are provided. The following table indicates how dosage may be adjusted depending on tablet size and body weight. Subsequent doses should be given at 24-hour intervals.

    Tablet Size Approximate Animal Weight Initial Dose 25 mg/lb (55 mg/kg) Subsequent Daily Doses 12.5 mg/lb (27.5 mg/kg) 125 mg 5 lb (2.2 kg) 1 tablet 1/2 tablet 250 mg 10 lb (4.5 kg) 1 tablet 1/2 tablet 500 mg 20 lb (9.1 kg) 1 tablet 1/2 tablet

    Treatment may be initiated with Albon Injection 40% to obtain effective blood levels almost immediately or to facilitate treatment of the fractious animal.

    Length of treatment depends on the clinical response. In most cases treatment for 3–5 days is adequate. Treatment should be continued until the animal is asymptomatic for 48 hours.

Login To Your Free Account